Denteric
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
L 9/31 Queen St, Melbourne, Victoria, 30...Website
www.denteric.comRevenue
<$5 MillionIndustry
About Denteric
Denteric is focused on developing a first-in-class therapeutic, GPV381, aimed at treating chronic inflammation, specifically targeting severe periodontitis caused by the bacterium Porphyromonas gingivalis. The therapy works by inhibiting gingipains, toxins that contribute to inflammation and tissue damage. Denteric's innovative approach not only addresses periodontal disease but also has potential implications for other conditions such as Alzheimer's disease, diabetes, and cardiovascular disease. The company is supported by a highly skilled industry team and caters to both patients and healthcare professionals.Explore more
SIC Code 28,283NAICS Code 32,325Show moreDenteric Org Chart
Compare Similar Companies to Denteric
Compare insights from companies similar to Denteric, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Denteric Tech Stack
A closer look at the technologies used by Denteric
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Denteric
Sign Up For FreeTo access detailed company insights
Denteric is focused on developing a first-in-class therapeutic, GPV381, aimed at treating chronic inflammation, specifically targeting severe periodontitis caused by the bacterium Porphyromonas gingivalis. The therapy works by inhibiting gingipains, toxins that contribute to inflammation and tissue damage. Denteric's innovative approach not only ad... Read More